Release Date: 17/02/14 09:14 Summary: Management Discussion & Analysis December 2013 Price Sensitive: No Download Document 60.65KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%